VSTM - Verastem signals confidence in AVMAPKI FAKZYNJA CO-PACK growth and prepares for pivotal 2026 clinical milestones
2025-11-04 10:17:10 ET
More on Verastem
- Verastem, Inc. (VSTM) Q3 2025 Earnings Call Transcript
- Verastem, Inc. 2025 Q3 - Results - Earnings Call Presentation
- Verastem: Navigating Critical Steps In Commercialization And Development (Downgrade)
- Verastem Q3 2025 Earnings Preview
- Verastem climbs on Q2 beat as new ovarian cancer drug boosts topline